StockNews.com Begins Coverage on Oncternal Therapeutics (NAS

StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a research note published on Tuesday morning. The brokerage issued a sell rating on the stock. A number of other analysts also recently issued reports on ONCT. HC Wainwright downgraded shares of Oncternal Therapeutics from a buy rating to a neutral rating […]

Related Keywords

San Diego , California , United States , Jamesb Breitmeyer , Davidf Hale , , Renaissance Technologies , Maxim Group , Healthcare Of Ontario Pension Plan Trust Fund , Oncternal Therapeutics Inc , Cantor Fitzgerald , Waypoint Capital Advisors , Oncternal Therapeutics Company Profile , Oncternal Therapeutics , Get Rating , Capital Management , Capital Advisors , Ontario Pension Plan Trust Fund , Sigma Investments , Two Sigma Advisers , Sigma Advisers , Oncternal Therapeutics Daily , Nasdaq Onct , Conct , Medical , Initiated Coverage , Stocknews Com ,